Atopic Dermatitis (Eczema)
This study is for participants, ages 6+, with Atopic Dermatitis (AD), also called Eczema. Symptoms must be present for at least three months if between the ages 6-17, or 6 months if 18+.
The study investigates a topical cream, applied once daily, to reduce inflammation and improve symptoms associated with AD. 2 in 3 participants (67%) will receive the actual drug, and 1 in 3 participants (33%) will receive a placebo.
Study participants will receive compensation for their participation.
This study is open at our Northshore and Southshore locations,
Call us at:
504-455-1310 (Metairie) or
985-900-2400 (Covington) to see if you qualify.
You may also fill out the contact form below: